Organisation paid for research Program year 2025 Source: CMS Open Payments

Prairie Eye Center Ltd

Neither a doctor nor a teaching hospital

Research payments

$1,992,806

234 payments

Through program year 2025, Prairie Eye Center Ltd is reported as receiving $1,992,806 in research payments, across 234 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$228,725	151
2023	Research	$16,151	2
2022	Research	$526,344	24
2021	Research	$768,547	31
2020	Research	$330,539	12
2019	Research	$122,500	14

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $1,672,397 80 payments
Alcon Research LLC $173,321 2 payments
Regeneron Pharmaceuticals, Inc. $143,885 151 payments
ANI Pharmaceuticals, Inc. $3,204 1 payment

Studies the money was for Research payments · program years 2019–2025

Ah and Imaging Biomarker Study $646,923 16 payments
Va2 Phiii $604,154 19 payments
Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt and Latanoprost in Patients with Elevated Intraocular Pressure (IOP) $173,321 2 payments
Va2 Phiii Rhine $157,252 19 payments
A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients With Diabetic Macular Edema $143,885 151 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $109,879 9 payments
A Phase III Study to Evaluate Faricimab in Patients With Branch Retinal Vein Occlusion $85,797 5 payments
A Phase III Study to Evaluate Faricimab in Patients With Central Retinal Vein Occlusion $44,662 5 payments
Faricimab Dme Long Term Extension Rhone X $23,731 7 payments
New Day Study $3,204 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.